CDRE Stock Analysis: Buy, Sell, or Hold?

CDRE - Cadre Holdings, Inc.

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
$40.01
-0.13 (-0.32%) β–Ό
HOLD
LOW Confidence
Protect Your CDRE Gains
Last Updated: January 30, 2026
Earnings: Mar 10, 2026

Get Alerted When CDRE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: CDRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$52.93
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$32.87
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CDRE is currently trading at $40.01, which is considered oversold relative to its 30-day fair value range of $41.14 to $43.38. The stock's valuation (Forward PE: 27.5) is in line with its historical norms (28.4). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This pessimistic expectation contrasts with the company's recent 198.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, CDRE is in a strong uptrend. The price is currently testing key support at $39.45. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $48.50 (+20.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $41.14 - $43.38
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 83.5%

Protect Your Profits

Holding CDRE? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 20.8% below Wall St target ($48.50)
  • CAUTION: Recommendation downgraded due to -7.9% 5-day decline

Fair Price Analysis

30-Day Fair Range $41.14 - $43.38
Current vs Fair Value OVERSOLD
Expected Move (7 Days) Β±$2.75 (6.9%)

Support & Resistance Levels

Support Level $39.45
Resistance Level $46.11
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 27.49
Wall Street Target $48.50 (+20.8%)
Revenue Growth (YoY) 42.5%
Earnings Growth (YoY) 198.9%
Profit Margin 7.3%
Valuation Discount vs History -1.1% cheaper
PE vs Historical 27.5 vs 28.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.1% (market-implied from PE analysis)
1-Year Target $39.70 (-1%)
2-Year Target $39.26 (-2%)
3-Year Target $38.83 (-3%)
3-Yr Target (if PE normalizes) (PE: 27β†’28) $40.11 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 27.5, Growth: 11.5%) $55.57 (+38%)
Base: (SPY PE: 22.3, Growth: 11.5%) $45.07 (+12%)
Bear: (PE: 19.0, Growth: 11.5%) $38.31 (-5%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 36.34 | Current EPS (TTM): $1.11
Bull Case $58.37 (+46%)
Analyst growth 31.5%, PE expands to 40.0
Base Case $53.06 (+33%)
Market implied 31.5%, PE stable at 36.3
Bear Case $27.43 (-31%)
Severe decline -20.0%, PE contracts to 30.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.5 to 28.4
Stabilization Target: $41.46 (+3.3%)
PE Expansion Potential: +3.3%
Last updated: January 30, 2026 10:53 PM ET
Data refreshes hourly during market hours. Next update: 11:53 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Aerospace & Defense Stocks

Top-rated stocks in Aerospace & Defense by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BA
The Boeing Company
BUY
30 analysts
$258 54 HOLD
HWM
Howmet AerospaceΒ Inc
STRONG BUY
25 analysts
$247 57 HOLD
LHX
L3Harris Technologies Inc
STRONG BUY
25 analysts
$364 58 HOLD
TDG
Transdigm Group Incorpor…
STRONG BUY
23 analysts
$1622 65 BUY
RTX
Raytheon Technologies Co…
BUY
24 analysts
$203 64 BUY

Advanced CDRE Option Strategies

Professional options setups generated by AI based on today's CDRE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CDRE

CDRE Technical Chart CDRE Price Prediction CDRE Earnings Date CDRE Investment Advisor CDRE Fair Price Analyzer CDRE Options Advisor CDRE Options Chain CDRE Options Analysis CDRE Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals